An interventional study of PECBLOCK under echoguidance in Cancer and Pain, sponsored by Centre hospitalier de l'Université de Montréal (CHUM). Completed at 2 sites in 2 countries. Open to female participants aged 18 Years to 85 Years. Per ClinicalTrials.gov, last updated 2019-10-03.
Sponsored by Centre hospitalier de l'Université de Montréal (CHUM) · Not applicable, Interventional, and Treatment
Pain after breast cancer surgery could be severe and about 1/3 of patients will develop chronic pain. The PECBLOCK is the injection of local anesthetics between the two pectoral muscles to block pectoral nerves and intercostal nerves innervating the breast. The aim of this study is to evaluate the efficacy of the PECBLOCK performed under echoguidance in minor and major breast surgery. The prevention of chronic pain following surgery will also be evaluated.
Centre hospitalier de l'Université de Montréal (CHUM) is the lead sponsor of 370 studies on the registry; 110 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Active drug given through PECBLOCK in these patients.
Procedure: PECBLOCK under echoguidance
Placebo drug given through PECBLOCK in these patients
Procedure: PECBLOCK under echoguidance
Performance of block under echography
Pain score at rest in the recovery room
Using a 0-10 verbal numerical scale where 0 is no pain and 10 the worst pain imaginable
Time frame: 30 min after entering the recovery room or just before morphine administration if needed
Total morphine consumption in the recovery room
When surgery is over and the patient is brought to the recovery room, the total morphine consumption in mg used in the recovery (for pain less than 4/10) is recorded
Time frame: in the recovery room before discharge (after 1 h on average))
Total sufentanil consumption during surgery
When surgery is over, 1-2 h on average depending if it is a tumorectomy or a mastectomy, the total sufentanil consumption in micrograms during surgery is recorded.
Time frame: at the end of surgery (1-2 h on average)
Assess any complication from PECBLOCK
Cardiovascular collapse, anaphylactic shock, hematoma, bleeding..?
Time frame: first 24 hours post surgery
This study is completed, as verified in Jul 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Centre hospitalier de l'Université de Montréal (CHUM)